BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33382365)

  • 41. Update on the diagnosis and management of autoimmune encephalitis.
    Ellul MA; Wood G; Tooren HVD; Easton A; Babu A; Michael BD
    Clin Med (Lond); 2020 Jul; 20(4):389-392. PubMed ID: 32675144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characterization of autoimmune encephalitis and psychosis.
    Hao Q; Wang D; Guo L; Zhang B
    Compr Psychiatry; 2017 Apr; 74():9-14. PubMed ID: 28081431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosing autoimmune encephalitis based on clinical features and autoantibody findings.
    Bien CG
    Expert Rev Clin Immunol; 2019 May; 15(5):511-527. PubMed ID: 30676128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis.
    Casciato S; Morano A; Fattouch J; Fanella M; Avorio F; Albini M; Basili LM; Cerulli Irelli E; Viganò A; De Risi M; Grammaldo LG; D'Aniello A; Mascia A; Manfredi M; Quarato P; Giallonardo AT; Di Gennaro G; Di Bonaventura C
    J Neurol Sci; 2019 Jan; 396():102-107. PubMed ID: 30447604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis].
    Prüß H
    Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune encephalitis: a review of diagnosis and treatment.
    Dutra LA; Abrantes F; Toso FF; Pedroso JL; Barsottini OGP; Hoftberger R
    Arq Neuropsiquiatr; 2018 Jan; 76(1):41-49. PubMed ID: 29364393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the pathologist in the diagnosis of autoimmune encephalitis.
    Rao S; Netravathi M; Mahadevan A
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S198-S206. PubMed ID: 35562150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges.
    Dale RC; Gorman MP; Lim M
    Curr Opin Neurol; 2017 Jun; 30(3):334-344. PubMed ID: 28234797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune Encephalitis.
    Qiu X; Zhang H; Li D; Wang J; Jiang Z; Zhou Y; Xu P; Zhang J; Feng Z; Yu C; Xu Z
    Front Immunol; 2019; 10():1286. PubMed ID: 31231392
    [No Abstract]   [Full Text] [Related]  

  • 50. Encephalitis with antibodies against the GABA
    Chen X; Liu F; Li JM; Xie XQ; Wang Q; Zhou D; Shang H
    Neurol Res; 2017 Nov; 39(11):973-980. PubMed ID: 28974152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoimmune encephalitis associated with vitiligo?
    Haitao R; Huiqin L; Tao Q; Xunzhe Y; Xiaoqiu S; Wei L; Jiewen Z; Liying C; Hongzhi G
    J Neuroimmunol; 2017 Sep; 310():14-16. PubMed ID: 28778439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proportion and spectrum of movement disorders in adolescent and adult patients of autoimmune encephalitis of non-neoplastic aetiology.
    Dash D; Ihtisham K; Tripathi M; Tripathi M
    J Clin Neurosci; 2019 Jan; 59():185-189. PubMed ID: 30455136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.
    Steiner J; Prüss H; Köhler S; Frodl T; Hasan A; Falkai P
    World J Biol Psychiatry; 2020 Apr; 21(4):241-254. PubMed ID: 30513253
    [No Abstract]   [Full Text] [Related]  

  • 54. Autoimmune Encephalitis: Distinguishing Features and Specific Therapies.
    Co DO; Kwon JM
    Crit Care Clin; 2022 Apr; 38(2):393-412. PubMed ID: 35369953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function.
    Heine J; Prüss H; Bartsch T; Ploner CJ; Paul F; Finke C
    Neuroscience; 2015 Nov; 309():68-83. PubMed ID: 26012492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomodulation in the acute phase of autoimmune encephalitis.
    Ciano-Petersen NL; Muñiz-Castrillo S; Vogrig A; Joubert B; Honnorat J
    Rev Neurol (Paris); 2022; 178(1-2):34-47. PubMed ID: 35000790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis.
    Calvat P; Leung C; Bost C; Fortenfant F; Simonetta-Moreau M; Pariente J; Rafiq M; Brefel-Courbon C; Rascol O; Fabbri M; Ory-Magne F
    Parkinsonism Relat Disord; 2023 Feb; 107():105232. PubMed ID: 36509623
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hashimoto's encephalitis, report of a case].
    Zamora Elson M; Labarta Monzón L; Mallor Bonet T; Villacampa Clavér V; Avellanas Chavala M; Seron Arbeloa C
    Med Intensiva; 2014 Nov; 38(8):522-3. PubMed ID: 24169265
    [No Abstract]   [Full Text] [Related]  

  • 59. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: Case report and literature review.
    Wei YC; Tseng JR; Wu CL; Su FC; Weng WC; Hsu CC; Chang KH; Wu CF; Hsiao IT; Lin CP
    Brain Behav; 2020 Mar; 10(3):e01540. PubMed ID: 31985135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease.
    Salazar R
    Clin Neurol Neurosurg; 2018 May; 168():72-76. PubMed ID: 29525731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.